GRAL · Nasdaq · CIK 0001699031

GRAIL, Inc.

GRAIL, Inc.’s most recent SEC filing in our snapshot is a Form 4 filed on Oct 16, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $147.2M and net income of -$408.4M, according to its XBRL data on EDGAR. Its EDGAR record lists 39 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$147.2M
Net income, FY2025
-$408.4M
Form 4 filings on record, past 12 months
39

Company overview

Legal name (as filed)
GRAIL, Inc.
Ticker
GRAL
SEC Central Index Key (CIK)
0001699031
Industry (SIC)
Services-Medical Laboratories (code 8071)
Business address
SUNNYVALE, CA
State or country of incorporation
DE
Fiscal year ends
December 31
SEC filer category
Non-accelerated filer<br>Emerging growth company
Position in SEC ticker list
#1253 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from GRAIL, Inc.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$55.5MFY2023$93.1MFY2023$125.6MFY2024$147.2MFY2025
Net income
-$5.4BFY2023-$1.5BFY2023-$2.0BFY2024-$408.4MFY2025
GRAL annual results
ItemFY2023
ended Jan 1, 2023
FY2023
ended Dec 31, 2023
FY2024
ended Dec 31, 2024
FY2025
ended Dec 31, 2025
Revenue$55.5M$93.1M$125.6M$147.2M
Net income-$5.4B-$1.5B-$2.0B-$408.4M
Diluted EPS-$173.89-$47.21-$63.54-$11.11
Total assets—$3.9B$3.0B$2.9B
Cash and equivalents$241.6M$97.3M$214.2M$249.7M

XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

GRAL latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Mar 12, 202610-KAnnual report· period Dec 31, 2025Document · Index
Aug 6, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Aug 5, 20268-KResults of operations· period Aug 5, 2026Document · Index
Apr 28, 2026DEF 14ADefinitive proxy statement· period Jun 18, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about GRAIL, Inc., by form type:

4 ×19144 ×7SCHEDULE 13G/A ×58-K ×410-Q ×23 ×1SCHEDULE 13G ×1DEFA14A ×1
GRAL recent filings
FiledFormWhat it isOriginal
Oct 16, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 15, 2026Document · Index
Oct 16, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 15, 2026Document · Index
Oct 16, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 15, 2026Document · Index
Oct 16, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 15, 2026Document · Index
Oct 15, 2026144Notice of proposed sale of securitiesDocument · Index
Oct 7, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 5, 2026Document · Index
Oct 7, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 5, 2026Document · Index
Oct 5, 2026144Notice of proposed sale of securitiesDocument · Index
Oct 5, 2026144Notice of proposed sale of securitiesDocument · Index
Sep 23, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 21, 2026Document · Index
Sep 23, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 21, 2026Document · Index
Sep 21, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 31, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 27, 2026Document · Index
Aug 31, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 27, 2026Document · Index
Aug 27, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 27, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 13, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Aug 7, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Aug 6, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Aug 6, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Aug 5, 20268-KResults of operations· period Aug 5, 2026Document · Index
Jul 28, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Jul 16, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 15, 2026Document · Index
Jul 16, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 15, 2026Document · Index
Jul 16, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 15, 2026Document · Index
Jun 22, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 18, 2026Document · Index
Jun 22, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 18, 2026Document · Index
Jun 22, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 18, 2026Document · Index
Jun 22, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 18, 2026Document · Index
Jun 22, 20268-KShareholder vote results· period Jun 18, 2026Document · Index
Jun 5, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 4, 2026Document · Index
Jun 3, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 1, 2026Document · Index
Jun 3, 2026144Notice of proposed sale of securitiesDocument · Index
Jun 2, 20263Initial statement of beneficial ownership· period Jun 1, 2026Document · Index
Jun 1, 20268-KDirector or officer change; Other events· period Jun 1, 2026Document · Index
May 15, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
May 11, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
May 7, 202610-QQuarterly report· period Mar 31, 2026Document · Index
May 5, 20268-KResults of operations· period May 5, 2026Document · Index
Apr 28, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index

Insider filing activity

39 Form 4 filings appear in GRAIL, Inc.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Services-Medical Laboratories

All 17 companies in Services-Medical Laboratories· Companies headquartered in California

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001699031 and XBRL company facts. GRAIL, Inc. on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.